The Society for Neuro-Oncology is a multidisciplinary organization dedicated to promoting advances in neuro-oncology through research and education.
Now in its twenty fourth year, the Society continues to grow and mature as the premier North American organization for clinicians, basic scientists, nurses and other health care professionals whose focus is central nervous system tumors in children and adults.
The annual meeting includes three days of scientific programs and one education day for practitioners.
The ASTMH Annual Meeting draws tropical medicine and global health professionals representing academia, government, non-profits, philanthropy, NGOs, industry, military and private practice. The meeting is designed for researchers, professors, government and public health officials, military personnel, travel clinic physicians, practicing physicians in tropical medicine, students and all health care providers working in the fields of tropical medicine, hygiene and global health.
The Annual Meeting is a five-day educational conference that includes four pre-meeting courses and draws approximately 4,600 attendees.
The CAPHLD is a network of over thirty local public health laboratories that perform state-of-art testing to detect outbreaks of foodborne, respiratory, and rash illness, to determine new trends in communicable disease, conducts timely diagnostic testing to detect and characterize influenza virus, tuberculosis and other agents, responds to a variety of public health emergencies including bioterrorism threats, environmental spills, rabies infection in domestic and wild animals, and conducts testing drinking, ocean, lake and stream and waste water to ensure protection of the public.
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association's membership includes more than 7,500 lung cancer specialists in over 100 countries.
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association's membership includes more than 7,500 lung cancer specialists in over 100 countries.
Next Generation Dx Summit, entering its eleventh year, brings together more than 800 diagnostics professionals from across the world, providing comprehensive programming and valuable networking opportunities with key opinion leaders in the diagnostics industry. Back in 2009, the inaugural meeting was created with the purpose of bringing together all of the major players in the evolving areas of diagnostics to discuss improvements in technology research and development with an emphasis on applications in the clinic and commercialization.
The CGC annual meeting is a forum for education and discussion of best practices in laboratory genomics. The CGC is committed to advancing clinical diagnostics through the use of genomic technologies (microarray, massively parallel sequencing, etc.) and improving the accompanying data processing. This meeting brings together laboratorians, clinicians and researchers with a shared interest in early adoption, performance and interpretation of leading edge technology for cancer and constitutional genomics.
More than 350 microbiology and biology educators come from a wide range of institutions – from community colleges to international universities – to fully immerse themselves in biological sciences at the ASM Conference for Undergraduate Educators (ASMCUE).
The conference program includes plenary, concurrent, poster, and exhibit sessions. Participants engage in formal and informal small group discussions between colleagues all focused on the same goal: to improve teaching and learning in the biological sciences.
The mission of the AHA Basic Cardiovascular Sciences Scientific Sessions is to promote interaction among participants from diverse disciplines through lectures, poster presentations and informal discussions.
ince 1995, the InfoAg Conference has been the premier event for discussion and advancement of precision agriculture. This event draws interest from domestic and international agriculture professionals and features a wide range of educational and networking opportunities for professionals interested in learning more about precision agriculture techniques.
Each year, the International Association for Food Protection hosts an Annual Meeting, providing attendees with information on current and emerging food safety issues, the latest science, innovative solutions to new and recurring problems, and the opportunity to network with thousands of food safety professionals from around the globe. Held in various locations throughout North America, this meeting has grown over the years to become the leading food safety conference worldwide. IAFP 2019 will be held at the Kentucky International Convention Center in Louisville, Kentucky.
The IAFP Annual Meeting is attended by more than 3,600 of the top industry, academic and governmental food safety professionals from six continents. This renowned event owes its reputation and success to the quantity, quality, and diversity of each year’s program; the quality and relevance of exhibits sharing the latest in available technologies; leading experts speaking on a variety of timely topics; and special recognition of outstanding professionals and students for their contributions in the food safety field.
The Congress is the first meeting of its kind, and will include a balanced program encompassing six areas of wheat research: Wheat Diversity, Evolution, and Genetic Resources; Structural and Functional Genomics of Wheat and Wheat Relatives; Wheat Improvement: Breeding, Physiology, and Enabling technologies; Wheat Production Systems: Environment, Sustainability, and Management; Protecting Yield: Resistance to Biotic and Abiotic Stresses; Wheat Uses: Functionality, Nutrition, Safety and Human Health.
The Congress will include joint plenary sessions and concurrent sessions, with over 100 invited speakers presenting. All plenary sessions will be streamed live on the web and social media platforms. Two poster sessions, field trips, cultural activities, as well as social events for networking will round out the weeks event.
The ASAS CSAS (American Society of Animal Science and Canadian Society of Animal Science) Annual Meeting and Trade Show provides the attendees with the opportunity to join in the meeting with the opening session with a series of TED style talks about animal science and animal agriculture, enjoy various other events, and much more.
Communicating Innovation in Plant Science.
As a global forum for professionals, educators, and students, the Annual Meeting of the American Dairy Science Association will attract more than 1,700 dairy foods and production specialists from 51 countries with common but diverse interests in the future of dairy science.
The CCMG scientific conference is the largest gathering of healthcare professionals, trainees and decision-makers, with a focus on medical genetics, in Canada. Featuring high-profile keynote speakers; cutting-edge panels on current issues in genetics; and a wealth of networking activities, the conference is the country’s premier event for evidence-informed discussion and debate on health care.
ASM Microbe 2019, sponsored by the American Society for Microbiology, allows scientists to showcase research to the world of microbial scientists and delve into scientific interests and specialties with sessions in eight specialty tracks.
Visit Illumina at Booth #1343!
Each year the BIF symposium draws a large group of leading seedstock and commercial beef producers, academics and allied industry partners. Program topics focus on how the beef industry can enhance value through genetic improvement across a range of attributes that affect the value chain.
The conference will cover all three sections of the Canadian Society of Microbiologists: Applied & Environmental Microbiology, Infection and Immunity as well as Molecular Genetics and Cellular Microbiology.
APHL 2019 is a four-day conference of more than 600 professionals that addresses public health laboratory issues, trends and technologies relative to emerging infectious disease, environmental health, emergency preparedness, informatics, food safety, newborn screening, global health and more. It consists of a member assembly, plenary sessions, general and breakout sessions, roundtables, posters and exhibits. This conference, APHL's annual membership meeting, is open to anyone with an interest in the work of public health laboratories.
CROPS is an international conference that brings together leading genomics researchers and plant breeders to explore emerging applications of new genomic technology to crop improvement.
Today’s genomic solutions. Tomorrow’s cancer breakthroughs.
Join us at ASCO 2019 to learn how Illumina genomic solutions are enabling comprehensive genomic profiling, including fusion detection, agnostic of fusion partner. With advancements in the understanding of the role of NTRK fusions in advanced solid tumors, and the potential for TKI inhibitors, it’s more important than ever to detect and characterize these rare fusion events. However, not all detection methods are equal. In fact, 60% of NTRK fusion partners can be missed by commercially available amplicon-based NTRK detection assays. Learn how Illumina NGS technology detects more fusions, including NTRK fusions. With genomic advancements comprehensive fusion detection, the possibilities are limitless.
Visit us at booth 24111 and at our events to learn more.
Industry Expert Theater presentation
Industry Expert Theater
Saturday, June 1
9:30–10:30 AM
Title: Comprehensive NTRK fusion detection, agnostic of the fusion partner, for identification of rare genomic events: perspectives from an oncologist and pathologist
Speakers:
Phil Febbo, Oncologist and SVP, Chief Medical Officer, Illumina
Sue, Beruti, Pathologist and Senior Director, Illumina
Please join us for a unique opportunity where we will bring together speakers from across the academic, clinical, and biotechnology spectrum to discuss how they are using next-generation sequencing in this exciting space. Whether you are interested in advancing your research, bringing game-changing therapies to market, or partnering to maximize the effectiveness of translational studies, this event aims to provide the research community with insights and ideas all under the same roof.
Explore the impact of health disparities research, functional properties of single cell, and epigenetic biomarkers and circulating methylome snapshots to gain deeper insight into the etiology of human disease at this symposium hosted by USC’s Keck Genomics Platform and Illumina.
In this second annual symposium, content should appeal to a wide range of researchers seeking to apply translational genomics into relevant clinical features.
Location: Aresty Conference Center, University of Southern California, Los Angeles, CA
Date: Wednesday, May 29, 2019
Time: 8:00 AM - 5:00 PM PT
“Sequencing, Finishing and Analysis in the Future” (SFAF) is an annual meeting dedicated to bringing together experts in the genomics field—including representatives from the industries that serve this specialized scientific community.
The meeting focuses on laboratory methods and computational tools used to help sequence, assemble, and finish genomes, including new sequencing technologies, which promise high-throughput results by sequencing more base-pairs per run at longer read-lengths.
This annual meeting includes diverse disciplines within the arteriosclerosis, thrombosis, vascular biology, peripheral vascular disease, vascular surgery, and functional genomics research communities that allow investigators to explore areas of cross-disciplinary interests. In association with: Arteriosclerosis, Thrombosis and Vascular Biology Council; Peripheral Vascular Disease Council; Genomics & Precision Medicine Council.
Watch this presentation to hear more about a novel approach that uses hybrid avatars and perturbation biology. The idea is to use complementary data to extract immunologically relevant information.
By combining the analysis of RNA sequencing and image data, Prof. Zlatko Trajanoski’s lab in Innsbruck has devised a powerful workflow that will enable precision immuno-oncology.
An annual conference hosted by the American Society for Microbiology (ASM) covering the latest on microbiome-virome interactions, RNA sequencing for viral diagnosis, the challenges and opportunities for a universal influenza vaccine, and more.
Join us at the ACOG Annual Clinical and Scientific Meeting 2019 to learn how NIPT provides safe, early, and accurate insights by screening from a single maternal blood draw as early as 10 weeks gestational age. Visit us at booth 1801 to learn more about the value of NIPT in your practice.
Location: Music City Center, Nashville, TN
This webinar will discuss the benefits of virus-specific target capture combined with next-generation sequencing (NGS) to identify viral infections and conduct comprehensive genomic and transcriptomic interrogation.
The high diversity of inter-virus genome types and intra-virus genomic heterogeneity, together with the complexity of sample types, make NGS-based clinical virology difficult, arduous, and expensive. A single method that is able to use nucleic acids that are of low quantity and poor quality to examine both DNA and RNA viruses from a mixed cell population that may include human, bacteria, and viruses would be ideal.
To this end, our speaker, Darrell L. Dinwiddie of the University of New Mexico Health Sciences Center, will discuss a method his team has been evaluating that uses virus-specific target capture probe sets coupled with NGS.
Dr. Dinwiddie will discuss how this method has demonstrated significant improvement in respiratory viral identification and genome coverage compared to unenriched NGS. His team has shown the ability to effectively capture and sequence viruses that may differ from the probes by as much as 10 percent to 15 percent. These methods have worked for viral sequencing from purified viral stocks, in vitro cell culture, and clinical samples.
This webinar will also address the broader implications of this work, including surveillance, epidemiologic studies, and public health planning.
For example, in two hospital outbreak studies, Dr. Dinwiddie and colleagues have shown that target capture and NGS enabled sensitive discrimination of the relatedness of respiratory syncytial virus and human parainfluenza virus 3 isolates obtained during the outbreak and provided evidence for source of transmission.
In addition, through multi-year retrospective and prospective NGS studies of respiratory viral infections at multiple pediatric hospitals, Dr. Dinwiddie and his team have been able to examine seasonal respiratory virus genomic variation, evolution, and distribution for several respiratory viruses. This includes evaluating the match of vaccine to circulating influenza virus strains and the correlation between virus strains and clinical severity of infections. The recently developed Human Pan Viral sequencing methods by Illumina and Twist Biosciences will enable similar studies not only for respiratory viruses, but for all types of human viral pathogens across all sample types of interest.
Darrell L. Dinwiddie, PhD
Assistant Professor, Department of Pediatrics
Scholar, Clinical Translational Science Center
University of New Mexico Health Sciences Center
The annual Frontiers in Pediatric Genomic Medicine Conference brings leaders in research, industry and healthcare together to explore advances in translating genomic diagnostics into targeted treatment for patients in neonatal and pediatric intensive care.
Advances in research and technology now afford us the unique opportunity to develop and test novel diagnostics and therapeutics. This conference takes advantage of the collective experience and expertise of its speakers in drug discovery. A broad range of policy, research, and venture topics are covered.
Advances in next-generation sequencing technology and computational data analysis have revolutionized efforts to identify tumor-specific mutant antigens. These altered, potentially immunogenic proteins may prove to be an important target for immunotherapies. In this Cell Press Webinar, Nicholas McGranahan (University College London) and Gerald Linette (University of Pennsylvania) will review progress made and future applications of this important area of cancer immunogenomics.
Bio-IT World includes in-depth technical presentations in 17 tracks, education opportunities at 14 workshops, three expert-judged awards programs, and face-to-face conversations, including 3,400+ attendees from 40+ countries.
Cancer arises due to an accumulation of genetic alterations, which can lead to the production of mutant proteins not expressed in normal cells, allowing recognition by the immune system. Kellie Smith, PhD, Assistant Professor of Oncology at Johns Hopkins University School of Medicine, presents her research on understanding the interplay of cancer neoantigens with the immune response at Illumina Exhibitor Spotlight Theater presentation at AACR 2019.
The Annual Clinical Genetics Meeting is hosted by The American College of Medical Genetics and Genomics (ACMG). The meeting offers the opportunity for the medical genetics community to come together and learn the about latest research, therapies and practical implementation. The 2019 ACMG Meeting will feature the ACMG/Society of Inherited Metabolic Disorders (SIMD) Joint Session on Saturday, April 6. The two societies meet together once every four years — so be sure to plan your schedule to stay for this important session developed in collaboration between ACMG and SIMD.
This meeting connects a diverse group of over 3000 members of the Medical Genetics community for four days of professional growth, education, networking and collaboration. Come and join them to find out what’s shaping the future of genetics and genomics.
Visit Illumina at Booth #804!
Join us at AACR 2019 to learn about our latest advancements in cancer research. Explore the possibilities of TruSight™ Oncology 500, which enables comprehensive tumor profiling, and find out how from whole exome to whole genome to whole transcriptome sequencing, Illumina is your trusted partner in genomics research.
Visit us at booth 2621 or at our Exhibitor Spotlight Theater presentation to learn more about how Illumina can help advance your research.
Exhibitor Spotlight Theater presentation:
“Driving Precision Oncology Research: From Routine Detection of Tumor Mutational Burden (TMB) to Neoantigen Discovery and the Immune Response.”
Speakers:
Carlo Bifulco, MD
Member and Director, Translational Molecular Pathology, Medical Director, Molecular Genomics, Providence Portland Medical Center
Kellie Smith, Ph.D.
Assistant Professor of Oncology, Johns Hopkins University School of Medicine
Location: Exhibit Theater B, Hall B, GWCC
Date: Tuesday, April 2, 2019, 3:00–4:00 PM
ABRF 2019, "30 Years of Challenging the Limits of Science and Technology, Opening Doors for the Future" , will bring together international leaders in core disciplines to provide a vision of what can be done, and insight toward making further progress.
Highlights of the ABRF 2019 Annual Meeting include scientific sessions and workshops that allow presenters and attendees to explore and discuss in-depth critical scientific and technical issues encountered in biomolecular core facilities.
Visit Illumina at Booth #310!
Studies in genomics, transcriptomics, and epigenomics have shaped our understanding of cellular complexity and heterogeneity. Technological advances are now enabling cost-efficient, high-throughput analysis of biological molecules, and have offered researchers an opportunity to combine the interrogation of DNA, RNA, and epigenome in order to better understand genotype-phenotype interactions.
In this seminar, we will review recent research that incorporates multi-omic approaches and introduce the tools that enabled this research, which include sequencing and array-based technologies, and library prep solutions for both bulk and single-cell analysis. Information on core services will be provided by Christina Harrington.
Speakers Include:
Part 1: Transforming the Future of Genomics Together, with Gary Schroth, Distinguished Scientist, Illumina, Inc.
Learn about the most recent product developments from Illumina in library preparation, next-generation sequencing (NGS) systems, and informatics. Illumina Distinguished Scientist, Gary Schroth, presents a short overview on the newest in end to end next-generation sequencing (NGS) solutions as well as exciting new options for the future.
Part 2: HiSeq™, NovaSeq™, and iSeq™: Project Transitions to Leverage Larger Scale Sequencing, with Shawn Levy, Director of the HudsonAlpha Institute for Biotechnology
The latest sequencing technologies enable unprecedented throughput and redefine limits for many labs. Join Shawn Levy, Faculty Investigator at the HudsonAlpha Institute for Biotechnology, as he presents data demonstrating how multiple Illumina sequencing systems can be utilized together in a lab setting to facilitate larger scale sequencing.
Data volumes are growing more rapidly than ever before. Join Menzies Chen, Illumina Product Manager, as he discusses the newest informatics features to support high throughput, high volume sequencing. With DRAGEN™ technology, bioinformatics workflows can now be run on specialized hardware to accelerate the speed of analysis.
The latest sequencing technologies enable unprecedented throughput and redefine limits for many labs. Join Shawn Levy, Faculty Investigator at the HudsonAlpha Institute for Biotechnology, as he presents data demonstrating how multiple Illumina sequencing systems can be utilized together in a lab setting to facilitate larger scale sequencing.
Illumina product development presents the next era of library prep. The new Nextera™ DNA Flex and Nextera™ DNA Flex for Enrichment library prep solutions deliver consistent insert sizes, uniform coverage, optimized performance, and highly reproducible data across all Illumina sequencing systems. This bead-based technology minimizes bias and opportunities for error, resulting in highly reproducible sequencing data.
See what new product developments are available in the Illumina sequencing portfolio. Join David Miller from Illumina Product Marketing, as he presents data in support of new software, robust sequencing kit performance, and longer reads on a variety of next-generation sequencing (NGS) systems from Illumina.
NTRK fusions are rare but important recent biomarkers linked to response to new TRK inhibitors. Comprehensive genomic profiling on all solid tumors permits detection of rare genomic events and in the future may enables the use of emerging treatments such as NTRK inhibitors. NTRK genes include numerous potential fusion partners, large intronic regions and G-C rich content, making accurate and comprehensive detection of NTRK fusions difficult to perform in the lab. Amongst the variable performance of NTRK fusion assays, NTRK detection from RNA using Hybrid-Capture NGS provides comprehensive and accurate fusion detection, agnostic of the fusion partner.
Phillip Febbo, MD
Chief Medical Officer, Illumina, Inc.
Maude Champagne
Clinical Oncology Marketing, Illumina, Inc.
The Advances in Genome Biology and Technology meeting brings together technology, software, applications, data resources and public policy. AGBT provides a forum for exchanging information about the latest advances in DNA sequencing technologies, experimental and analytical approaches for genomic studies, and their myriad applications.
Gary Schroth, Distinguished Scientist, Illumina, Inc. and Shawn Levy, Director, HudsonAlpha Institute for Biotechnology will be giving a presentation entitled: “HiSeq, NovaSeq, and iSeq: Project transitions to leverage larger scale sequencing”.
Visit Illumina at Caxambas 1!
This meeting of the International Association for the Study of Lung Cancer is designed to provide information about ongoing clinical trials of the newest therapies for lung cancer. The meeting presenters summarize the data on relevant targets for new therapies. Data on preclinical and early clinical data are presented for each of the drugs directed against these targets. The meeting also presents data on early predictive biomarkers. There are also presentations from fellows and young investigators in training and debates about controversial topics. The meeting is a unique resource for clinical investigators, including those in academia, clinical practice and industry.
Join us for a seminar to learn how Illumina technology can help you uncover the answers to drive your research forward.
During this event, Illumina experts will present an overview of informatics tools, next-generation sequencing (NGS), and arrays to highlight recent application and platform updates, and discuss the basic concepts and key advantages over traditional technologies.
Topics covered include:
The Society for Maternal-Fetal Medicine gathers each winter for The Pregnancy Meeting to share the latest innovations in research and clinical care. Through educational seminars and research presentations, this conference brings together MFMs in training, practicing clinicians and veterans in the field. Participants are invited to share their clinical wisdom, original research, and passion for improving outcomes for mothers and babies.
Hosted by the:
The Joint PulseNet/OutbreakNet Mountain/West Regional Meeting will bring together laboratorians, epidemiologists, and environmental health specialists involved with foodborne and enteric disease outbreak response. Issues discussed will include surveillance and outbreak detection of enteric diseases. Combined sessions and discipline-specific sessions are planned over the course of the meeting.
International Society for Stem Cell Research (ISSCR) Annual Meeting hasmore than 3,500 attendees, speakers, exhibitors, sponsors, and media. The meeting brings together everyone from senior scientists to trainees to discover, share, and network with leading innovators in the stem cell community.
The Precision Medicine World Conference (PMWC), in its 16th installment, will take place in the Santa Clara Convention Center (Silicon Valley) on January 20-23, 2019. The program will traverse innovative technologies, thriving initiatives, and clinical case studies that enable the translation of precision medicine into direct improvements in health care. Conference attendees will have an opportunity to learn first-hand about the latest developments and advancements in precision medicine and cutting-edge new strategies and solutions that are changing how patients are treated.
Transforming the Future of Agriculture
Illumina is dedicated to advancing agrigenomics through product development, collaborations with consortia, and interaction with the community. We are excited to see you at the upcoming PAG XXVII conference in San Diego. Visit us at booth 319 to see our Edico Genome Dragen system, speak to our technical experts about our agrigenomics solutions, or arrange a private meeting in our suite.
Illumina Highlights:
This webinar discusses the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.
Our speaker, David Haslam of Cincinnati Children's Hospital, details methods used to eradicate colonization with pathogenic organisms and hopefully prevent bloodstream infections. He also discusses how bacterial whole genome sequencing and shotgun metagenomics can be used to track and prevent transmission of hospital-acquired infections.
Dr. Haslam shares how this work fits within his lab's goal of identifying risk factors for invasive infection due to multidrug resistant bacteria. His team is applying next generation sequencing and metagenomic analysis to identify changes in the microbiome that correlate with risk for invasive infection and is currently developing this assay into a clinically actionable test.
Microbiome research is quickly becoming one of the most exciting fields in the life sciences, driven by the power of next-generation sequencing (NGS). One Codex is a leading platform for rapid, accurate microbiome and metagenomics analysis and is used by researchers across major academic, commercial, and clinical institutions. In this webinar, we will walk through a gut microbiome experiment including sample collection, sequencing, bioinformatics, and analysis.
On the bioinformatics side, we will show how you can easily analyze NGS datasets with the One Codex database of >80,000 whole microbial genomes. We will review several types of microbiome analyses from taxonomic classification to building predictive machine learning models. Finally, we will demonstrate how it can all be performed in a scalable, repeatable fashion, ensuring that your microbiome research is reproducible whether it involves 10 samples or 10,000.
Understanding the microbial ecosystem dynamics of our planet is central to our role as custodians of the planet. The Earth Microbiome Project aimed to characterize the microbial diversity of the diverse ecosystems across our world, which we have used to model the ecosystem dynamics of these environments. Integrating these models with agricultural policy provides a framework on which to determine how climate change and shifting policy will influence the microbial metabolic dynamics, which will affect our ability to modulate system scale outcomes. In concert with this global perspective we are also characterizing the human microbiome, which has become a key part of patient care, provide new avenues to diagnose and treat human disease. The immune system controls our interaction with the microbial world, and yet the microbial communities in our bodies are central to modulating the immune response. Changes in the human microbiome have substantial influence on atopy, neurological disorders, metabolic disorders, and a range of complex conditions and disease states. We will discuss evidence of these mechanisms of interaction and how we have started to disturb the delicate balance of the immune-microbe equilibrium, impacting the development and function of our immune systems. Central to this disturbance is the distance we have placed between our children and the microbial world, which has been demonstrated to have a substantial influence on their physiological, immunological, neurological and even endocrinological development. Applying new strategies to identify how the microbial ecosystem correlates with diseases states and treatment efficacy through Microbiome-Wide Association Studies (MWAS) is altering the trajectory of precision medicine, and providing a new framework for facilitating patient care.
Jack Gilbert
Jack Gilbert is the Faculty Director of the Microbiome Center, a Professor in the Department of Surgery at the University of Chicago Medicine, Senior Scientist (Adjunct) at Marine Biological Laboratory, and Group Leader in Microbial Ecology at Argonne National Laboratory. Gilbert's research is focused on the ecology, evolution, and metabolic dynamics of microbial ecosystems from myriad environments including built environments, oceans, rivers, soils, air, plants, animals, and humans. His primary interest is in using omics technologies (metagenomics, metatranscriptomics, metabolomics) to capture longitudinal dynamics in microbial ecosystems and then model how these interactions relate the environmental variables, be those variables disease onset and immunology in humans or chemical transformations in plants and soils. Gilbert is developing unifying principles which govern how microbial communities assemble. He founded the Earth Microbiome Project, and co-founded the American Gut Project, and is the editor-in-chief of the journal mSystems.
Genomics is facilitating a deeper understanding of cancer biology and through clinical research, new biomarkers are emerging that pave the way for next-generation therapeutics to help fight cancer in a more personalized way.
In this webinar, Sandip Patel, MD will provide a review of biomarker research and discoveries in the field of Immunotherapy and Garret Hampton, PhD will discuss Illumina’s vision for Oncology and share how genomics will enable broader availability of comprehensive tumor sequencing to explore complex biomarkers and assess tumor mutational burden.
Explore our smallest and most cost-effective sequencer ever. Join Bellal Moghis and Gary Schroth as they introduce our newest system—iSeq 100. They’ll walk through installation and also review applications and methods. Find out how you can make the most of your new lab partner.
See what happens when a leading library prep is optimized to run on next-generation sequencing (NGS) systems from Illumina. Join Mitu Chaudhary and Claire White as they present data to demonstrate the robust performance of AmpliSeq for Illumina from a wide variety of sample types.
Next Generation Sequencing (NGS) methods are arguably responsible for the establishment of the field of metagenomics. Significantly lower nucleic acid input requirements have made it possible to sample microbial communities that would have been deemed undetectable just a few years ago. In addition to technological advancements, the continued decline in the cost of sequencing has made it feasible to survey the thousands of samples necessary for metagenomic analyses. To meet the throughput demands of these studies, we have automated NGS sample processing methods from nucleic acid extraction, through library normalization, and pooling. Here, we will present automated methods for 16S rDNA amplicon and whole genome shotgun sequencing as well as discuss the impact of automation on quality. The resulting sequencing reads from both approaches were compared for quality metrics using our standard quality matrix (Q30, Cluster Density, number of mapped reads, etc.) Subsequently, sequencing reads were used for taxonomic identification and a comparative analysis. Although both automated methods offer a significant benefit in throughput, we found the reduction in the risk of human error far outweighs all other benefits. Furthermore, utilization of automated liquid handling reduces the risk of contamination. |
For Research Use Only. Not for use in diagnostic procedures.